ghk-cu alopecia clinical trial Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application GHK-Cu Peptide Research: Molecular Mechanisms

WHAT STEP DO I USE THIS IN MY ROUTINE

Research on GHK-Cu for skin in women (including both clinical trials measuring skin density and dermatological studies on photoaging) consistently show meaningful results at the 12 mg/day injectable dose range or equivalent topical coverage

Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B

Choosing the Right Injection Site Ideal SubQ Sites: Abdomen 2 inches away from the navel Thighs front of the upper leg Upper arms back of the upper arm (best if done by someone else) Rotate Sites Consistently: Using a rotation chart prevents repeated trauma and allows the tissue to recover

Some of those claims have genuine preclinical backing